Table 1

Characteristic of participants

CharacteristicHealthy control groupType 2 diabetes DPN patient group
Age group 1Age group 2Age group 3Age group 1Age group 2Age group 3
Male/female (n)101010101010101010101010
Age (years)44.6±1.845.9±1.855±3.254.4±2.763.6±2.365.8±2.144.9±2.845.5±1.855±2.254.1±2.564.1±3.262.3±1.9
Height (cm)176±6.5162±6.7173±6.6163±6.9173±6.7167±10.1173±6.7164±7.4177±5.2166±4.8174±4.3166±6.4
Weight (kg)66±5.256±5.069.9±6.256.8±7.168.9±5.564.5±9.667.3±8.059.5±7.271.6±4.565.6±4.368.6±6.364.8±4.6
BMI (kg/m2)21.4±2.121.3±1.023.3±1.021.4±1.623.0±1.023.0±1.322.3±1.622.1±1.822.9±1.123.7±0.322.7±1.323.4±0.5
Duration of diabetesNNNNNN4±34±2.27.4±4.36.2±3.114±914.3±7.2
Systolic BP (mm Hg)119±10113±9121±11125±13123±16122±12118±7116±4124±8120±5125±3125±4
Diastolic BP (mm Hg)80±577±882±483±585±485±282±376±581±580±385±383±4
HbA1c (%)4.7±0.64.5±0.45.2±0.35.3±0.65.3±0.55.4±0.37.3±0.37.4±0.38.1±0.37.9±0.78.6±0.48.4±0.5
Low-Density Lipoprotein Cholesterol (mmol/L)2.19±0.52.4±0.62.53±0.42.63±0.23.02±0.52.93±0.72.73±0.82.66±0.63.1±0.43.02±0.43.08±0.33.08±0.5
TCSSNNNNNN6.7±0.56.8±0.47.6±0.37.4±0.47.8±0.27.7±0.2
  • Values are expressed as means±SD.

  • 'N' means no duration of diabetes.

  • BMI, body mass index; BP, blood pressure; DPN, diabetic peripheral neuropathy; TCSS, Toronto Clinical Scoring System.